Description

Suprax (Cefixime) is used to treat adults with acute bronchitis, uncomplicated urinary tract infections, and sore throat/tonsillitis.

 

 

 

	Quantity	Strength	Price	Our Guarantees
	10 Tab(s)	50mg	$9.00
	10 Tab(s)	100mg	$11.00
	20 Tab(s)	100mg	$19.00
	30 Tab(s)	100mg	$25.00
	60 Tab(s)	100mg	$40.00
	5 Tab(s)	200mg	$9.00
	10 Tab(s)	200mg	$17.00
	20 Tab(s)	200mg	$32.00
	30 Tab(s)	200mg	$48.00
	60 Tab(s)	200mg	$79.00

SUPRAX (cefixime) is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms:

Uncomplicated Urinary Tract Infections caused by Escherichia coli and Proteus mirabilis.

Otitis Media caused by Haemophilus influenzae (beta-lactamase positive and negative strains), Moraxella (Branhamella) catarrhalis, (most of which are beta-lactamase positive) and S. pyogenes*.

Note: For information on otitis media caused by Streptococcus pneumoniae, see CLINICAL STUDIES section.

Pharyngitis and Tonsillitis, caused by S. pyogenes.

Note: Penicillin is the usual drug of choice in the treatment of S. pyogenes infections, including the prophylaxis of rheumatic fever. SUPRAX is generally effective in the eradication of S. pyogenes from the nasopharynx; however, data establishing the efficacy of SUPRAX in the subsequent prevention of rheumatic fever are not available.

Acute Bronchitis and Acute Exacerbations of Chronic Bronchitis, caused by Streptococcus pneumoniae and Haemophilus influenzae (beta-lactamase positive and negative strains).

Uncomplicated gonorrhea (cervical/urethral), caused by Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains).

Appropriate cultures and susceptibility studies should be performed to determine the causative organism and its susceptibility to SUPRAX; however, therapy may be started while awaiting the results of these studies. Therapy should be adjusted, if necessary, once these results are known.

* Efficacy for this organism in this organ system was studied in fewer than 10 infections.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Suprax (cefixime) tablets and oral suspension and other antibacterial drugs, Suprax (cefixime) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.